Clinical Trial

Effectiveness of Gut Microbiota-targeted Diatery Intervention Among People Living With HIV

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 12, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to conduct a dietary intervention targeting HIV specific gut microbiota alterations for primary atherosclerotic cardiovascular disease (ASCVD) prevention and evaluate its effectiveness in preventing ASCVD among people living with HIV (PLWH). Participants in the intervention group will receive the gut microbiota-targeted dietary intervention thrice weekly for 3 months, accompanied by bi-weekly healthy diet guidance for the same duration. Meanwhile, the control group will continue routine follow-up and health education practices. The intervention will span three months, followed by a three-month follow-up period. Data collection will occur at baseline, 3 months, and 6 months.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06498401
Lead Sponsor Fudan University
Conditions HIV, Atherosclerosis, Diet, Healthy
Enrollment 110 participants
Start Date 2024-07-20
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-12